Selexis has been setting the pace of innovation in protein expression and establishing new benchmarks in bioproduction for  two decades.

1 min read

Selexis SA to Partner at the BIO-Europe Spring 2011 Partnering Conference

Mar 11, 2011 12:30:51 PM

Geneva, Switzerland (PRWEB) March 11, 2011 – Selexis SA, a Swiss-based biotechnology company with technologies for the rapid development and engineering of high yield and stable mammalian cell lines for therapeutic protein manufacturing of recombinant drugs announced today that representatives from the Company will be participating in the BIO-Europe Spring 2011 Partnering Conference being held March 14-16, 2011, at the Milano Convention Center in Milan, Italy. Dr. Armelle Gaussin, CTO and Dr. Denise Huber, Director, Business Development will be taking part in the pre-scheduled meetings.

Companies or individuals attending BIO-Europe Spring can schedule meetings with Selexis (registration required) by visiting:

Selexis Partnering Schedule
Monday, March 14, 2011: 1:30 PM - 6:30 PM
Tuesday, March 15, 2011: 8:00 AM - 6:30 PM
Wednesday, March 16, 2011: 8:00 AM - 5:00 PM

Topics: 2011